Two faces of caspase-8

Nature Immunology

Volumn 3, Issue 10, 2002, Pages 896-898

  Barnhart, Bryan C ^a   Peter, Marcus E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CASPASE 8; CD20 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 0036793171     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1002-896     Document Type: Note

References (13)

1. Cerretti, D. P. et al. Science 256, 97-100 (1992).
2. Thornberry, N. A. et al. Nature 356, 768-774 (1992).
3. Chun, H. J. et al. 419, doi:10.1038/nature01063 (2002).
4. Yeh, W. C. et al. Science 279, 1954-1958 (1998).
5. Zhang, J. et al. Nature 392, 296-300 (1998).
6. Varfolomeev, E. E. et al. Immunity 9, 267-276 (1998).
7. Alam, A. et al. J. Exp. Med. 190, 1879-1890 (1999).
8. Kennedy, N. J. et al. J. Exp. Med. 190, 1891-1896 (1999).
9. Hu, W. H., Johnson, H. & Shu, H. B. J. Biol. Chem. 275, 10838-10844 (2000).
10. Chaudhary, P. M. et al. Oncogene 19, 4451-4460 (2000).
11. Zornig, M. et al., Curr Biol. 8, 467-470 (1998).
12. Walsh, C. M. et al. Immunity 8, 439-449 (1998).
13. Newton, K. et al. EMBO J. 17, 706-718 (1998).